UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
PCSK9 Inhibition: From Current Advances to Evolving Future Review article
2022
Authors:  Liu, Chunping;  Chen, Jing;  Chen, Huiqi;  Zhang, Tong;  He, Dongyue; et al.
Favorite | TC[WOS]:40 TC[Scopus]:46  IF:5.1/6.0 | Submit date:2022/11/07
Cardiovascular Disease  Pcsk9 Inhibitors  Clinical Applications  Security  Research Status  
Engineered extracellular vesicles and their mimetics for cancer immunotherapy Journal article
Liu, Chunping, Wang, Yichao, Li, Longmei, He, Dongyue, Chi, Jiaxin, Li, Qin, Wu, Yixiao, Zhao, Yunxuan, Zhang, Shihui, Wang, Lei, Fan, Zhijin, Liao, Yuhui. Engineered extracellular vesicles and their mimetics for cancer immunotherapy[J]. JOURNAL OF CONTROLLED RELEASE, 2022, 349, 679-698.
Authors:  Liu, Chunping;  Wang, Yichao;  Li, Longmei;  He, Dongyue;  Chi, Jiaxin; et al.
Favorite | TC[WOS]:80 TC[Scopus]:84  IF:10.5/10.6 | Submit date:2022/08/02
Extracellular Vesicles  Exosomes  Cancer Immunotherapy  Immune Reprogramming  Immunogenic Cell Death